Gene · 2053
Papers2,484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the impact of sEH inhibition on intestinal cell differentiation and Colon Cancer: Insights from TPPU treatment. | Toxicol Appl Pharmacol | 2024 | 39414156 | PubTator, text mining | PubMed |
| Discovery of glycosidated glycyrrhetinic acid derivatives: Natural product-based soluble epoxide hydrolase inhibitors. | Eur J Med Chem | 2024 | 39413443 | PubTator, text mining | PubMed |
| Soluble Epoxide Hydrolase Inhibition Attenuates Proteinuria by Alleviating Renal Inflammation and Podocyte Injuries in Adriamycin-Induced Nephropathy. | Int J Mol Sci | 2024 | 39408958 | PubTator, text mining | PubMed |
| A regulatory loop involving the cytochrome P450-soluble epoxide hydrolase axis and TGF-β signaling. | iScience | 2024 | 39398242 | PubTator, text mining | PubMed |
| Differential lipid signaling from CD4+ and CD8+ T cells contributes to type 1 diabetes development. | Front Immunol | 2024 | 39359722 | PubTator, text mining | PubMed |
| Randomized, double-blind, phase 1a single-ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers. | Clin Transl Sci | 2024 | 39300734 | PubTator, text mining | PubMed |
| Restoration of ARA metabolic disorders in vascular smooth muscle cells alleviates intimal hyperplasia. | Eur J Pharmacol | 2024 | 39265882 | PubTator, text mining | PubMed |
| Characteristics of membrane transport, metabolism, and target protein binding of cyclic depsipeptide destruxin E in HeLa cells. | Drug Metab Pharmacokinet | 2024 | 39265438 | PubTator, text mining | PubMed |
| Automated design of multi-target ligands by generative deep learning. | Nat Commun | 2024 | 39261471 | PubTator, text mining | PubMed |
| Gasdermin D-mediated metabolic crosstalk promotes tissue repair. | Nature | 2024 | 39260418 | PubTator, text mining | PubMed |
| Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease. | Eur J Med Chem | 2024 | 39243456 | PubTator, text mining | PubMed |
| Biosynthesis of resolvin D1, resolvin D2, and RCTR1 from 7,8(S,S)-epoxytetraene in human neutrophils and macrophages. | Proc Natl Acad Sci U S A | 2024 | 39236243 | PubTator, text mining | PubMed |
| Methylglyoxal Affects the Expression of miR-125b, miR-107, and Oxidative Stress Pathway-associated Genes in the SH-SY5Y Cell Line. | Adv Pharm Bull | 2024 | 39206401 | PubTator, text mining | PubMed |
| Preclinical Evaluation of Soluble Epoxide Hydrolase Inhibitor AMHDU against Neuropathic Pain. | Int J Mol Sci | 2024 | 39201526 | PubTator, text mining | PubMed |
| Targeting the soluble epoxide hydrolase pathway as a novel therapeutic approach for the treatment of pain. | Curr Opin Pharmacol | 2024 | 39197248 | PubTator, text mining | PubMed |
| Inhibition of Soluble Epoxide Hydrolase by Cembranoid Diterpenes from Soft Coral Sinularia maxima: Enzyme Kinetics, Molecular Docking, and Molecular Dynamics. | Mar Drugs | 2024 | 39195489 | PubTator, text mining | PubMed |
| Corn Peptides Alleviate Nonalcoholic Fatty Liver Fibrosis in Mice by Inhibiting NLRP3 Inflammasome Activation and Regulating Gut Microbiota. | J Agric Food Chem | 2024 | 39166383 | PubTator, text mining | PubMed |
| The role of soluble epoxide hydrolase in the intestine. | Cell Biol Int | 2024 | 39164961 | PubTator, text mining | PubMed |
| sEH activity is associated with mortality in patients with ARDS: a retrospective cohort study. | Biomark Med | 2024 | 39136398 | PubTator, text mining | PubMed |
| New Diaryl-1,2,4-triazolo[3,4-a]pyrimidine Hybrids as Selective COX-2/sEH Dual Inhibitors with Potent Analgesic/Anti-inflammatory and Cardioprotective Properties. | ACS Omega | 2024 | 39130606 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2053/papers?page=9